Skip to main content
Research project

Developing Immunomodulatory Monoclonal Antibodies to Promote Cancer Immunity

Project overview

Cancer Research UK Biotherapeutics Drug Discovery Programme


Other researchers

Professor Stephen Beers

Professor of Immunology & Immunotherapy

Research interests

  • Edit
  • Antibody Effector Functions Monoclonal antibodies (mAb) have become established in the treatment of a variety of malignancies - transforming patient outcomes. Despite this undoubted impact, responses remain variable and their mechanisms of action and of tumour resistance are controversial. Our research is focussed on understanding these complex processes using a variety of complementary models and systems to better inform antibody selection, design and clinical application.
  • Current research interests:

Connect with Stephen

Professor Aymen Al-Shamkhani

Professor in Immunology

Research interests

  • Cancer Immunotherapy
  • Immunobiology of costimulatory receptors
  • Immunostimulatory antibodies

Connect with Aymen

Dr Yury Bogdanov

Lecturer in Transgenic Technologies

Research interests

  • Tumour microenvironment
  • Neurotransmitters in Cancer
  • GABA and GABA receptors

Connect with Yury

Professor Peter Johnson CBE MD FRCP FMedSci

Professor of Medical Oncology

Connect with Peter

Collaborating research institutes, centres and groups

Back to top